Top Banner

of 37

Expert Consulting and Expert Witness Services

May 30, 2018

Download

Documents

lekshmisalim
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/14/2019 Expert Consulting and Expert Witness Services

    1/37

    http://www.pharmainfo.net/http://www.intota.com/rfp/rfp.asp?perID=724591http://www.pharmainfo.net/http://www.intota.com/http://www.intota.com/http://www.intota.com/rfp/rfp.asphttp://www.intota.com/help/default.asphttp://www.intota.com/aboutus/AboutUs.asphttp://www.intota.com/help/contact_us.asphttp://www.intota.com/SearchTips.asphttp://www.intota.com/help/default.asphttp://www.intota.com/help/privacy.asphttp://www.pharmainfo.net/http://www.pharmainfo.net/infohttp://www.pharmainfo.net/communityhttp://www.pharmainfo.net/pharmaceuticalarticleshttp://www.pharmainfo.net/e-journalhttp://www.pharmainfo.net/contacthttp://www.pharmainfo.net/userhttp://www.pharmainfo.net/http://www.pharmainfo.net/latest-reviewshttp://www.pharmainfo.net/volumes-and-issues/2007/vol-5-issue-6http://www.pharmainfo.net/volumes-and-issues/2007
  • 8/14/2019 Expert Consulting and Expert Witness Services

    2/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    3/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    4/37

    http://www.fda.gov/
  • 8/14/2019 Expert Consulting and Expert Witness Services

    5/37

    http://www.fda.gov/
  • 8/14/2019 Expert Consulting and Expert Witness Services

    6/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    7/37

    http://www.fda.gov/default.htmhttp://www.fda.gov/Drugs/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm053133.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Process%23Investigational%20New%20Drug%20Processhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Introduction%23Introductionhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Definitions%23Definitionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Types%20of%20INDs%23Types%20of%20INDshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Phases%20of%20an%20Investigation%23Phases%20of%20an%20Investigationhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Application%20FAQ's%23Investigational%20New%20Drug%20Application%20FAQ'shttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#pre-clinical%20studies?%23pre-clinical%20studies?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%23INDhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#submit%20an%20IND?%23submit%20an%20IND?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#forms?%23forms?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Instructions%23Instructionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%20number?%23IND%20number?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#When%20can%20I%20start%20clinical%20trials?%23When%20can%20I%20start%20clinical%20trials?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Form%201572?%23Form%201572?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#What%20is%20an%20IRB?%23What%20is%20an%20IRB?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#informed%20consent?%23informed%20consent?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contactshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contacts
  • 8/14/2019 Expert Consulting and Expert Witness Services

    8/37

    http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2004_register&docid=fr06ap04-20.pdfhttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=23&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXT
  • 8/14/2019 Expert Consulting and Expert Witness Services

    9/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    10/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    11/37

    http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090301.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm071098.htmhttp://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM083548.pdf
  • 8/14/2019 Expert Consulting and Expert Witness Services

    12/37

    http://www.fda.gov/Drugs/default.htmmailto:[email protected]
  • 8/14/2019 Expert Consulting and Expert Witness Services

    13/37

    http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069901.htmhttp://www.fda.gov/AboutFDA/CentersOffices/CDER/ContactCDER/CDEROmbudsman/default.htmhttp://www.aidsinfo.nih.gov/http://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htmhttp://www.fda.gov/default.htmhttp://www.fda.gov/AboutFDA/default.htmhttp://www.fda.gov/AboutFDA/ContactFDA/default.htmhttp://www.fda.gov/SiteIndex/default.htmhttp://www.fda.gov/SiteMap/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/default.htmhttp://www.fda.gov/RegulatoryInformation/FOI/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/Accessibility/default.htmhttp://www.fda.gov/AboutFDA/WorkingatFDA/NoFearAct/default.htmhttp://www.fda.gov/CombinationProducts/default.htmhttp://www.fda.gov/AdvisoryCommittees/default.htmhttp://www.fda.gov/ScienceResearch/default.htmhttp://www.fda.gov/RegulatoryInformation/default.htmhttp://www.fda.gov/Safety/default.htmhttp://www.fda.gov/EmergencyPreparedness/default.htmhttp://www.fda.gov/InternationalPrograms/default.htmhttp://www.fda.gov/NewsEvents/default.htmhttp://www.fda.gov/Training/default.htmhttp://www.fda.gov/ICECI/default.htmhttp://www.fda.gov/ForFederalStateandLocalOfficials/default.htmhttp://www.fda.gov/ForConsumers/default.htmhttp://www.fda.gov/ForIndustry/default.htmhttp://www.fda.gov/ForHealthProfessionals/default.htm
  • 8/14/2019 Expert Consulting and Expert Witness Services

    14/37

    http://www.fda.gov/default.htmhttp://www.hhs.gov/http://www.hhs.gov/http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#main%23mainhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#search%23searchhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#fda-topmenu%23fda-topmenuhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#section-menu%23section-menuhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#footer%23footerhttp://www.fda.gov/SiteIndex/default.htmhttp://www.fda.gov/default.htmhttp://www.fda.gov/Food/default.htmhttp://www.fda.gov/Drugs/default.htmhttp://www.fda.gov/MedicalDevices/default.htmhttp://www.fda.gov/BiologicsBloodVaccines/default.htmhttp://www.fda.gov/AnimalVeterinary/default.htmhttp://www.fda.gov/Cosmetics/default.htmhttp://www.fda.gov/Radiation-EmittingProducts/default.htmhttp://www.fda.gov/TobaccoProducts/default.htmhttp://www.addthis.com/bookmark.php?v=152&pub=fdamainhttp://www.accessdata.fda.gov/scripts/email/email.cfm
  • 8/14/2019 Expert Consulting and Expert Witness Services

    15/37

    http://www.fda.gov/default.htmhttp://www.fda.gov/Drugs/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/default.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm053133.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Process%23Investigational%20New%20Drug%20Processhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Introduction%23Introductionhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Definitions%23Definitionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Types%20of%20INDs%23Types%20of%20INDshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Phases%20of%20an%20Investigation%23Phases%20of%20an%20Investigationhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Investigational%20New%20Drug%20Application%20FAQ's%23Investigational%20New%20Drug%20Application%20FAQ'shttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#pre-clinical%20studies?%23pre-clinical%20studies?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%23INDhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#submit%20an%20IND?%23submit%20an%20IND?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#forms?%23forms?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Instructions%23Instructionshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IND%20number?%23IND%20number?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#When%20can%20I%20start%20clinical%20trials?%23When%20can%20I%20start%20clinical%20trials?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#Form%201572?%23Form%201572?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#What%20is%20an%20IRB?%23What%20is%20an%20IRB?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#IRB%20approval?%23IRB%20approval?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#marketed%20product%23marketed%20producthttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#informed%20consent?%23informed%20consent?http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contactshttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069898.htm#contacts%23contacts
  • 8/14/2019 Expert Consulting and Expert Witness Services

    16/37

    http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2004_register&docid=fr06ap04-20.pdfhttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=23&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXThttp://frwebgate.access.gpo.gov/cgi-bin/get-cfr.cgi?TITLE=21&PART=312&SECTION=34&YEAR=1999&TYPE=TEXT
  • 8/14/2019 Expert Consulting and Expert Witness Services

    17/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    18/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    19/37

    http://www.fda.gov/AboutFDA/CentersOffices/CDER/ucm090301.htmhttp://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/ucm071098.htmhttp://www.fda.gov/downloads/AboutFDA/ReportsManualsForms/Forms/UCM083548.pdf
  • 8/14/2019 Expert Consulting and Expert Witness Services

    20/37

    http://www.fda.gov/Drugs/default.htmmailto:[email protected]
  • 8/14/2019 Expert Consulting and Expert Witness Services

    21/37

    http://www.fda.gov/Drugs/DevelopmentApprovalProcess/SmallBusinessAssistance/ucm069901.htmhttp://www.fda.gov/AboutFDA/CentersOffices/CDER/ContactCDER/CDEROmbudsman/default.htmhttp://www.aidsinfo.nih.gov/http://www.fda.gov/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htmhttp://www.fda.gov/default.htmhttp://www.fda.gov/AboutFDA/default.htmhttp://www.fda.gov/AboutFDA/ContactFDA/default.htmhttp://www.fda.gov/SiteIndex/default.htmhttp://www.fda.gov/SiteMap/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/default.htmhttp://www.fda.gov/RegulatoryInformation/FOI/default.htmhttp://www.fda.gov/AboutFDA/AboutThisWebsite/Accessibility/default.htmhttp://www.fda.gov/AboutFDA/WorkingatFDA/NoFearAct/default.htmhttp://www.fda.gov/CombinationProducts/default.htmhttp://www.fda.gov/AdvisoryCommittees/default.htmhttp://www.fda.gov/ScienceResearch/default.htmhttp://www.fda.gov/RegulatoryInformation/default.htmhttp://www.fda.gov/Safety/default.htmhttp://www.fda.gov/EmergencyPreparedness/default.htmhttp://www.fda.gov/InternationalPrograms/default.htmhttp://www.fda.gov/NewsEvents/default.htmhttp://www.fda.gov/Training/default.htmhttp://www.fda.gov/ICECI/default.htmhttp://www.fda.gov/ForFederalStateandLocalOfficials/default.htmhttp://www.fda.gov/ForConsumers/default.htmhttp://www.fda.gov/ForIndustry/default.htmhttp://www.fda.gov/ForHealthProfessionals/default.htm
  • 8/14/2019 Expert Consulting and Expert Witness Services

    22/37

    http://www.allp.com/drug_dev.htmhttp://www.mindbranch.com/products/R198-014http://www.businessworldindia.com/http://www.pubs.acs.org/cen/coverstory/8004/8004pharmaceuticals.htmlhttp://www.pharmaquality.com/Cover%20Story5.htmhttp://www.fda.gov/cder/handbook/index.htm
  • 8/14/2019 Expert Consulting and Expert Witness Services

    23/37

    http://www.allp.com/drug_dev.htmhttp://www.fda.gov/cder/regulatory/applications/ind_page_1.htmhttp://www.fda.gov/cder/regulatory/applications/NDA.htmmailto:[email protected]
  • 8/14/2019 Expert Consulting and Expert Witness Services

    24/37

    http://www.pharmainfo.net/http://www.pharmainfo.net/http://www.pharmainfo.net/infohttp://www.pharmainfo.net/communityhttp://www.pharmainfo.net/pharmaceuticalarticleshttp://www.pharmainfo.net/e-journalhttp://www.pharmainfo.net/contacthttp://www.pharmainfo.net/userhttp://www.pharmainfo.net/http://www.pharmainfo.net/latest-reviews
  • 8/14/2019 Expert Consulting and Expert Witness Services

    25/37

    http://www.pharmainfo.net/volumes-and-issues/2007/vol-5-issue-6http://www.pharmainfo.net/volumes-and-issues/2007
  • 8/14/2019 Expert Consulting and Expert Witness Services

    26/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    27/37

    http://www.fda.gov/
  • 8/14/2019 Expert Consulting and Expert Witness Services

    28/37

    http://www.fda.gov/
  • 8/14/2019 Expert Consulting and Expert Witness Services

    29/37

  • 8/14/2019 Expert Consulting and Expert Witness Services

    30/37

    http://www.allp.com/drug_dev.htmhttp://www.mindbranch.com/products/R198-014http://www.businessworldindia.com/http://www.pubs.acs.org/cen/coverstory/8004/8004pharmaceuticals.htmlhttp://www.pharmaquality.com/Cover%20Story5.htmhttp://www.fda.gov/cder/handbook/index.htmhttp://www.allp.com/drug_dev.htmhttp://www.fda.gov/cder/regulatory/applications/ind_page_1.htmhttp://www.fda.gov/cder/regulatory/applications/NDA.htm
  • 8/14/2019 Expert Consulting and Expert Witness Services

    31/37

    mailto:[email protected]
  • 8/14/2019 Expert Consulting and Expert Witness Services

    32/37

    http://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/pharmaglowhttp://www.pharmainfo.net/pppc02http://www.pharmainfo.net/pharmacyschoolshttp://www.pharmainfo.net/bloghttp://www.pharmainfo.net/pharmacists-zone/fpgee-practice-questions-and-answershttp://www.pharmainfo.net/pharmaglow/pharmindia-competitions/2nd-group-discussion-competition/winnershttp://www.pharmainfo.net/reviews/%20/pharmaglow/powerpoint-presentation-competitions/pppc-03http://www.pharmainfo.net/reviews/spray-drying-reviewhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/reviews/functional-foodnutraceuticals-regulation-indiahttp://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenariohttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenario
  • 8/14/2019 Expert Consulting and Expert Witness Services

    33/37

    http://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/reviews/film-coating-technology-overviewhttp://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/reviews/pharmaceutical-micropellets-overviewhttp://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/reviews/cancer-therapy-ayurveda-systemic-reviewhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/reviews/rational-drug-use-concern-healthcare-professionalshttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/reviews/promising-novel-approaches-oral-delivery-poorly-soluble-drugs
  • 8/14/2019 Expert Consulting and Expert Witness Services

    34/37

    http://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/reviews/preformulation-and-quality-overall-summary-regulatory-insightshttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/reviews/phytopharmaceuticals-extensive-reviewhttp://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.pharmainfo.net/pharmaglowhttp://www.pharmainfo.net/pppc02http://www.pharmainfo.net/pharmacyschoolshttp://www.pharmainfo.net/bloghttp://www.pharmainfo.net/pharmacists-zone/fpgee-practice-questions-and-answershttp://www.pharmainfo.net/pharmaglow/pharmindia-competitions/2nd-group-discussion-competition/winnershttp://www.pharmainfo.net/reviews/%20/pharmaglow/powerpoint-presentation-competitions/pppc-03http://www.pharmainfo.net/reviews/spray-drying-review
  • 8/14/2019 Expert Consulting and Expert Witness Services

    35/37

    http://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/mukeshgohelhttp://www.pharmainfo.net/reviews/functional-foodnutraceuticals-regulation-indiahttp://www.pharmainfo.net/deepkaushikhttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenariohttp://www.pharmainfo.net/reviews/food-safety-and-standards-act-2006-paradigm-shift-indian-regulatory-scenariohttp://www.pharmainfo.net/mpalthurhttp://www.pharmainfo.net/reviews/film-coating-technology-overviewhttp://www.pharmainfo.net/anand-shahhttp://www.pharmainfo.net/reviews/pharmaceutical-micropellets-overviewhttp://www.pharmainfo.net/prabakar75http://www.pharmainfo.net/reviews/cancer-therapy-ayurveda-systemic-review
  • 8/14/2019 Expert Consulting and Expert Witness Services

    36/37

    http://www.biomedcentral.com/info/mediainformation/http://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/shantibhushanhttp://www.pharmainfo.net/reviews/rational-drug-use-concern-healthcare-professionalshttp://www.pharmainfo.net/atul-kadamhttp://www.pharmainfo.net/reviews/promising-novel-approaches-oral-delivery-poorly-soluble-drugshttp://www.pharmainfo.net/amolsmalpanihttp://www.pharmainfo.net/reviews/preformulation-and-quality-overall-summary-regulatory-insightshttp://www.pharmainfo.net/apexa-patelhttp://www.pharmainfo.net/reviews/phytopharmaceuticals-extensive-reviewhttp://www.pharmainfo.net/mohammad-ruhal-ainhttp://www.biomedcentral.com/abstracts/AGAH/1/op011/#content%23content
  • 8/14/2019 Expert Consulting and Expert Witness Services

    37/37